Use of Probiotics and Synbiotics in the Treatment of Small Intestinal Bacterial Overgrowth (SIBO) and Other Gastrointestinal Symptoms After Metabolic Bariatric Surgery: a Systematic Review and Meta-Analysis
- PMID: 39607556
- DOI: 10.1007/s11695-024-07599-2
Use of Probiotics and Synbiotics in the Treatment of Small Intestinal Bacterial Overgrowth (SIBO) and Other Gastrointestinal Symptoms After Metabolic Bariatric Surgery: a Systematic Review and Meta-Analysis
Abstract
Metabolic bariatric surgery is considered the most effective treatment for severe obesity, however it may be associated with the development of Small Intestinal Bacterial Overgrowth (SIBO) and other gastrointestinal symptoms (GIS). This study conducted a systematic review and meta-analysis to evaluate the effects of probiotics or synbiotics on GIS and SIBO in post- metabolic bariatric surgery patients. Five studies that investigated the effect of probiotics or synbiotics in the treatment of post-surgery GIS were included in the review, with three focusing on SIBO. For the meta-analysis, three studies assessed GIS, and two examined SIBO. The results showed that probiotics did not offer significant benefits in treating GIS or SIBO in these patients.
Keywords: Bariatric surgery; Gastrointestinal symptoms; Meta-analysis; Probiotics.
© 2024. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.
Conflict of interest statement
Declarations. Ethical Approval: For this type of study formal consent is not required. Informed Consent: Informed Consent does not apply. Competing Interests: The authors declare no competing interests.
Similar articles
-
Synbiotics, prebiotics and probiotics for solid organ transplant recipients.Cochrane Database Syst Rev. 2022 Sep 20;9(9):CD014804. doi: 10.1002/14651858.CD014804.pub2. Cochrane Database Syst Rev. 2022. PMID: 36126902 Free PMC article.
-
Probiotics for management of functional abdominal pain disorders in children.Cochrane Database Syst Rev. 2023 Feb 17;2(2):CD012849. doi: 10.1002/14651858.CD012849.pub2. Cochrane Database Syst Rev. 2023. PMID: 36799531 Free PMC article.
-
Synbiotics, prebiotics and probiotics for people with chronic kidney disease.Cochrane Database Syst Rev. 2023 Oct 23;10(10):CD013631. doi: 10.1002/14651858.CD013631.pub2. Cochrane Database Syst Rev. 2023. PMID: 37870148 Free PMC article.
-
Probiotics in infants for prevention of allergic disease.Cochrane Database Syst Rev. 2025 Jun 13;6(6):CD006475. doi: 10.1002/14651858.CD006475.pub3. Cochrane Database Syst Rev. 2025. PMID: 40511642 Review.
-
The Prevalence of Small Intestinal Bacterial Overgrowth in Patients with Non-Alcoholic Liver Diseases: NAFLD, NASH, Fibrosis, Cirrhosis-A Systematic Review, Meta-Analysis and Meta-Regression.Nutrients. 2022 Dec 9;14(24):5261. doi: 10.3390/nu14245261. Nutrients. 2022. PMID: 36558421 Free PMC article.
References
-
- Frank J. Origins of the obesity pandemic can be analysed. Nature. 2016;532(7598):149. https://doi.org/10.1038/532149a . - DOI - PubMed
-
- Meldrum DR, Morris MA, Gambone JC. Obesity pandemic: causes, consequences, and solutions-but do we have the will? Fertil Steril. 2017;107(4):833–9. https://doi.org/10.1016/j.fertnstert.2017.02.104 . - DOI - PubMed
-
- Tremmel M, Gerdtham UG, Nilsson PM, et al. Economic burden of obesity: a systematic literature review. Int J Environ Res Public Health. 2017;14(4):435. https://doi.org/10.3390/ijerph14040435 . (Published 2017 Apr 19). - DOI - PubMed - PMC
-
- Brown W, Shikora S, Liem R, et al. 7th IFSO global registry report. International federation for surgery of obesity and metabolism disorders. 2022. Available from: https://www.ifso.com/pdf/ifso-7th-registstry-report-2022.pdf . Accessed 21 Sept 2024.
-
- Høgestøl IK, Chahal-Kummen M, Eribe I, et al. Chronic abdominal pain and symptoms 5 years after gastric bypass for morbid obesity. Obes Surg. 2017;27(6):1438–45. https://doi.org/10.1007/s11695-016-2499-z . - DOI - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical